Wells Fargo Maintains Overweight on Repligen, Raises Price Target to $190

Benzinga · 1d ago
Wells Fargo analyst Brandon Couillard maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $175 to $190.